Rheumatoid Arthritis Clinical Trials in Birmingham, Alabama

4 studies are recruiting for rheumatoid arthritis in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

    This open-label, Phase I study will assess the safety and tolerability of surovatamig and characterise its PK and PD following subcutaneous administration to participants with RA or SLE.

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Research Site, Birmingham, Alabama
    Locations
    35 in total
    Run by
    AstraZeneca

    See if you can join NCT07201558 on ClinicalTrials.gov

  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
    Locations
    52 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03816345 on ClinicalTrials.gov

  3. A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

    The purpose of this study is to measure the safety, tolerability, PK, and PD of AZD5492 administered subcutaneously in adult participants with SLE or IIM or RA Study details include: • The study duration will be a minimum of 180 days in addition to the screening period. Additional follow-up visits …

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Research Site, Birmingham, Alabama
    Locations
    37 in total
    Run by
    AstraZeneca

    See if you can join NCT06916806 on ClinicalTrials.gov

  4. RA-PRO PRAGMATIC TRIAL

    The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Bendcare, LLC, Birmingham, Alabama
    Locations
    49 in total
    Run by
    University of Alabama at Birmingham

    See if you can join NCT04692493 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.